向乌干达西南部感染HIV的妇女提供计划生育券与产后早期启动避孕:一项随机对照试验
该随机对照试验在乌干达西南部一家公立转诊医院纳入感染HIV的产后妇女,比较计划生育券(含产后即时咨询)与标准照护对产后8周内启动现代避孕方法的影响。
要点
- 券组平均启动避孕时间5.9周(SD=2.4),短于对照组9.3周(SD=5,P<0.001)。
- 对照组停用避孕1至2周者13%高于券组5%(P=0.008),停用超过4周者10%高于券组2%(P=0.002)。
核心结论
- 结构良好、有时间限制的计划生育券项目似乎可提高产后早期避孕启动率和持续使用率,适用于面临经济、知识和结构性障碍的环境。
- 作者认为需进一步研究以明确券在赋权感染HIV妇女长期避免意外妊娠中的作用。
研究设计与样本
- 2016年10月至2018年6月在乌干达西南部一家公立转诊医院开展的随机对照试验。
- 本次期中分析纳入成年感染HIV的产后妇女,等量随机分配至计划生育券组或标准照护对照组。
- 入组时及产后6个月由访员施测问卷;主要结局为产后8周内启动现代计划生育方法。
- 试验注册号ClinicalTrials.gov NCT02964169。
主要发现
- 平均启动时间:券组5.9周(SD=2.4) vs 对照组9.3周(SD=5),P<0.001,券组较对照组缩短。
- 妊娠:标准照护组记录1例,券组无报告。
- 6个月随访期间更换避孕方法者:券组8例(5%) vs 对照组5例(4%),P=0.467,两组无显著差异。
关键数值与推荐
- 避孕方法构成两组无差异:注射剂为最多妇女选择(150例,50%),其中52%在实验组;每臂选择避孕套、口服避孕药或宫内节育器者均<10%。
- 入组时希望产后2年内生育者:券组87例(55%) vs 对照组86例(54%)。
- 既往妊娠为计划妊娠者:券组136例(86%) vs 对照组128例(81%)。
- 全部妇女均在接受抗逆转录病毒治疗;平均CD4计数:对照组396 cells/mm3(SD=61) vs 券组393 cells/mm3(SD=64)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 主要局限性是研究结果可能无法推广至公立机构避孕药具可及性未改善的环境。
- 作者指出需进一步研究以明确券在赋权感染HIV妇女长期避免意外妊娠中的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Unwanted pregnancies remain a burden for women living with HIV (WLWH). Family planning prevents unplanned pregnancies while promoting longer birth intervals, key strategies to eliminate perinatal transmission of HIV and promote maternal and child health. We evaluated the effect of a family planning voucher, inclusive of immediate postpartum counseling, on uptake, early initiation, and continuation of modern contraceptive methods among recently postpartum WLWH delivering at a publicly funded regional referral hospital in rural, southwestern Uganda. METHODS AND FINDINGS: We performed a randomized controlled trial between October, 2016 and June, 2018 at a referral hospital in southwestern Uganda. This interim analysis includes adult WLWH randomized and enrolled equally to receive a family planning voucher or standard of care (control). Enrolled postpartum WLWH completed an interviewer-administered questionnaire at enrollment and 6 months postpartum. Our primary outcome of interest for this analysis is initiation of a modern family planning method within 8 weeks postpartum. Secondary outcomes included family planning initiation at 12, 14, 16, and 20 weeks postpartum, family planning discontinuation and/or change, pregnancy incidence, and mean time without contraception. The trial was registered with clinicaltrials.gov (NCT02964169). At enrollment, half of the women in both the voucher (N = 87, 55%) and control (N = 86, 54%) groups wanted to have a child in 2 years postpartum. Over 80% of referent pregnancies in the voucher (N = 136, 86%) and control (N = 128, 81%) groups were planned. All women were accessing ART. The mean CD4 count was 396 cells/mm3 (SD = 61) for those enrolled in the control group versus 393 cells/mm3 (SD = 64) in the family planning voucher group. By 8 weeks postpartum, family planning was initiated in 144 (91%) participants in the voucher group and 83 (52%) participants in the control group (odds ratio [OR] 9.42; CI 4.67-13.97, P < 0.001). We also found high family planning uptake rates for both groups, with higher rates among the intervention group at 12 weeks (OR 5.66; CI 2.65-12.12, P < 0.001), 14 weeks (OR 2.51; CI 1.31-4.79, P < 0.001), 16 weeks (OR 4.02; CI 1.66-9.77, P = 0.001), and 20 weeks (OR 3.65; CI 1.40-9.47, P = 0.004) postpartum. The average time to family planning initiation was reduced to 5.9 weeks (SD = 2.4) for those in the voucher group compared to 9.3 weeks (SD = 5) in the control (P < 0.001). One pregnancy was recorded in the group receiving standard of care; none were reported in the voucher group. Method mix did not differ by group: injectables were selected by most women (N = 150, 50%), and 52% of this proportion were in the experimental arm, with <10% in each arm selecting condoms, oral contraception, or intrauterine devices (IUDs). Similar proportions of women changed contraceptive methods over the 6-month follow-up in the voucher and control groups (N = 8, 5% versus N = 5, 4%; P = 0.467). More women in the control group discontinued contraception for 1 to 2 weeks (N = 19, 13% versus N = 7, 5%; P = 0.008) or more than 4 weeks (N = 15, 10% versus N = 3, 2%; P = 0.002) compared to those given a family planning voucher. The main limitation of this study is that its findings may not be generalized to settings without improved availability of contraceptives in publicly funded facilities. CONCLUSION: These findings indicate that a well-structured, time-bound family planning voucher program appeared to increase early postpartum contraceptive uptake and continuation in a setting in which users are faced with financial, knowledge, and structural barriers to contraceptive services. Further work should clarify the role of vouchers in empowering WLWH to avoid unintended pregnancies over time. TRIAL REGISTRATION: ClinicalTrials.gov NCT02964169.
引用
- Atukunda EC, Mugyenyi GR, Obua C, et al. Provision of family planning vouchers and early initiation of postpartum contraceptive use among women living with HIV in southwestern Uganda: A randomized controlled trial. PLoS Med. 2019. PMID: 31226123. doi:10.1371/journal.pmed.1002832
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。